tiprankstipranks
Zotefoams PLC (GB:ZTF)
LSE:ZTF

Zotefoams (ZTF) AI Stock Analysis

21 Followers

Top Page

GB:ZTF

Zotefoams

(LSE:ZTF)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
419.00 p
▲(0.96% Upside)
Action:UpgradedDate:03/19/26
The score is driven primarily by attractive valuation (low P/E with a ~2% yield) and a solid financial rebound in 2025 with moderate leverage. These positives are tempered by weak technicals, with the stock trading below key moving averages and bearish momentum indicators.
Positive Factors
Specialist product niche
Zotefoams manufactures high-performance closed-cell crosslinked foams sold into diverse industrial end markets. That technical differentiation and multi-sector exposure support durable demand, pricing power in engineered applications, and customer stickiness that underpins repeat sales and margin resilience over months.
Negative Factors
Earnings volatility
Profitability has shown sharp swings (2024 loss despite revenue growth), indicating sensitivity to cost inflation, product mix or non-recurring items. Persistent earnings volatility complicates capital allocation, long-term budgeting and supplier/customer negotiations, raising execution risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialist product niche
Zotefoams manufactures high-performance closed-cell crosslinked foams sold into diverse industrial end markets. That technical differentiation and multi-sector exposure support durable demand, pricing power in engineered applications, and customer stickiness that underpins repeat sales and margin resilience over months.
Read all positive factors

Zotefoams (ZTF) vs. iShares MSCI United Kingdom ETF (EWC)

Zotefoams Business Overview & Revenue Model

Company Description
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, Continental Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performan...
How the Company Makes Money
Zotefoams makes money primarily by manufacturing and selling high-value polymer foam materials and related products to business customers. Its revenue model is predominantly product-sales driven: it produces foam blocks and other forms of foam mat...

Zotefoams Financial Statement Overview

Summary
Strong 2025 rebound with higher revenue and healthy profitability (gross margin ~33% and net margin ~14%) after a weak, loss-making 2024. Balance sheet leverage is moderate (debt-to-equity ~0.44 in 2025) but debt increased in 2025, and cash flow has been historically uneven despite solid 2025 operating and free cash flow.
Income Statement
74
Positive
Balance Sheet
71
Positive
Cash Flow
69
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue158.49M147.79M126.97M127.37M100.75M
Gross Profit52.90M46.13M41.05M38.73M26.57M
EBITDA31.26M12.28M23.41M22.16M15.67M
Net Income22.64M-2.75M9.24M10.01M4.38M
Balance Sheet
Total Assets227.09M174.75M175.61M170.36M159.38M
Cash, Cash Equivalents and Short-Term Investments13.98M10.53M6.29M10.59M8.05M
Total Debt57.01M43.56M37.86M38.41M42.40M
Total Liabilities97.02M65.39M59.85M60.82M61.60M
Stockholders Equity130.08M109.36M115.76M109.54M97.78M
Cash Flow
Free Cash Flow21.54M11.35M-702.00K14.03M3.83M
Operating Cash Flow35.50M25.00M7.78M21.12M10.90M
Investing Cash Flow-36.93M-13.34M-8.29M-7.09M-6.98M
Financing Cash Flow4.92M-7.41M-3.73M-11.53M-4.34M

Zotefoams Technical Analysis

Technical Analysis Sentiment
Negative
Last Price415.00
Price Trends
50DMA
399.62
Negative
100DMA
400.04
Negative
200DMA
388.22
Negative
Market Momentum
MACD
-14.91
Negative
RSI
42.63
Neutral
STOCH
79.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ZTF, the sentiment is Negative. The current price of 415 is above the 20-day moving average (MA) of 364.10, above the 50-day MA of 399.62, and above the 200-day MA of 388.22, indicating a bearish trend. The MACD of -14.91 indicates Negative momentum. The RSI at 42.63 is Neutral, neither overbought nor oversold. The STOCH value of 79.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ZTF.

Zotefoams Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
£175.63M8.6918.25%2.00%15.56%-92.94%
70
Outperform
£507.65M22.536.40%9.48%0.58%61.58%
66
Neutral
£4.03B60.706.17%3.45%2.36%-13.99%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
58
Neutral
£849.14M-28.06-6.85%1.34%-11.78%-92.61%
51
Neutral
£69.84M-1.25-8.05%-4.41%2.29%
46
Neutral
£249.62M131.420.79%2.44%-4.71%86.21%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ZTF
Zotefoams
360.00
128.36
55.41%
GB:CRDA
Croda International
2,890.00
318.57
12.39%
GB:ELM
Elementis
149.40
35.19
30.82%
GB:ESNT
Essentra
87.80
-3.19
-3.50%
GB:SYNT
Synthomer
42.70
-41.70
-49.41%
GB:VCT
Victrex
583.00
-114.29
-16.39%

Zotefoams Corporate Events

Business Operations and StrategyDividendsFinancial DisclosuresM&A Transactions
Zotefoams Delivers Record 2025 Profits as Global Expansion Strategy Accelerates
Positive
Mar 17, 2026
Zotefoams reported record 2025 results, with revenue up 7% to £158.5m and adjusted operating profit rising 26% to £22.8m, driven by margin improvement, strong cash generation and a higher final dividend. The group strengthened its balanc...
Executive/Board ChangesRegulatory Filings and Compliance
Zotefoams Executives Add Shares Under Incentive Plan
Neutral
Mar 16, 2026
Zotefoams has disclosed routine share dealings by senior management under its Share Incentive Plan, with Group CEO Ronan Michael Cox and Group CFO Nick Wright each purchasing 38 partnership shares at £3.9516 and receiving 10 and 9 matching sh...
Business Operations and StrategyFinancial Disclosures
Zotefoams Sets Online Presentation for 2025 Preliminary Results
Positive
Mar 11, 2026
Zotefoams plc has scheduled a live online presentation of its 2025 preliminary results for 17 March 2026, to be hosted by chief executive Ronan Cox and chief financial officer Nick Wright via the Investor Meet Company platform. The session, which ...
Regulatory Filings and Compliance
Zotefoams Executives Acquire Shares Under Incentive Plan
Neutral
Feb 13, 2026
Zotefoams plc has disclosed director dealings under its Share Incentive Plan, with Group CEO Ronan Michael Cox and Group CFO Nick Wright each acquiring partnership shares in the company on 11 February 2026 at £4.4528 per share. Both executive...
Business Operations and StrategyRegulatory Filings and Compliance
Zotefoams Moves Registered Office to Central London Address
Neutral
Jan 27, 2026
Zotefoams plc has changed its registered office address to Salisbury House, Finsbury Circus, London EC2M 7AQ, effective immediately following board approval and filing with Companies House. While the move is administrative in nature, it updates th...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Zotefoams Delivers Record 2025 Profits and Expands Funding for Growth Strategy
Positive
Jan 22, 2026
Zotefoams reported an unaudited 7.2% rise in 2025 revenue to £158.5m and a record 37.9% increase in adjusted pre-tax profit to £21.1m, both ahead of market expectations, driven by strong Q4 trading and robust growth in its EMEA and North...
Regulatory Filings and Compliance
Zotefoams CEO Increases Stake Through Share Incentive Plan
Neutral
Jan 15, 2026
Zotefoams plc has disclosed that its Group CEO, Ronan Michael Cox, has increased his beneficial interest in the company through participation in its Share Incentive Plan. On 12 January 2026, Cox purchased 37 partnership shares at £4.0187 each...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026